Welcome to the Website of VitamFero
Incorporated in late 2005, VitamFero SA is a privately held biotech company whose mission, founded on an innovative and patented technology (i.e. Toxo KO), is to create, develop, register and market novel anti-infectious vaccines, first against Apicomplexe parasites such as:
- Toxoplasma gondii (toxoplasmosis agent)
- Neospora caninum (neosporosis agent)
- Cryptosporidium parvum (cryptosporidiosis agent).
With headquarters in Evry (France) and laboratories in Tours (France), VitamFero is involved first in veterinary healthcare.